Investment Interests. Schedule 2.08 hereto lists all markets served by wireless telephone services in which Centennial holds minority partnership interests (collectively, the "Investment Interests"), in each case showing the number of total persons in a market ("total POPs") served by such wireless telephone service (computed in accordance with the estimate of the 1996 population of a Metropolitan Statistical Area ("MSA") or Rural Service Area ("RSA"), as derived from the 1997 Paul Kagan Associates populxxxxx xxxxmates), the percentage ownership interest of Centennial in such wireless telephone service and the number of "net POPs" (being the number of total POPs multiplied by Centennial's ownership interest). The numbers of total POPs and net POPs and the percentage ownership interests of Centennial listed on Schedule 2.08 are correct in all material respects.
Investment Interests. All applicable ROFR Rights and Co-Sale Rights for each Investment Interest shall have been exercised or waived by all parties having such rights. Purchaser shall have executed and delivered to Seller such instruments of sale, transfer, conveyance, assumption or assignment, including amendments to any Operative Documents, duly executed by Purchaser, as reasonably requested by Seller and as are reasonably necessary in order to transfer the Investment Interests.
Investment Interests. Do you have current investments (e.g., proprietorships, partnerships, joint ventures, board memberships, controlling interest in a company) valued at more than US $1,000 overall in a commercial entity with an interest related to the outcome of any projects handled by FIND or that you are advising on? Yes/No 1 This form is based on WHO’s DOI Form No. WHO 000 X XXX (23/09/2014)
Investment Interests. (a) No Target Group Members have any direct or indirect equity or other investment interests in, or any right to purchase any equity or other interests in, any other companies, corporations, partnerships, joint ventures, associations, or other subjects, including registered equities or beneficial ownership interests. Except Shanghai Shengyu Network Technology Co., Ltd., the Target Group Member is not a member of any partnership (and is not engaged in any part of the Primary Business through any partnership) and the Target Group Member is not involved in any joint venture or similar arrangement or has unlimited liability in any foreign investment.
Investment Interests. Do you have current investments (valued at more than US $5 000 overall) in a commercial entity with an interest related to the subject of the meeting or work? Please also include indirect investments such as a trust or holding company. You may exclude mutual funds, pension funds or similar investments that are broadly diversified and on which you exercise no control. Yes No 3a Stocks, bonds, stock options, other securities (e.g., short sales) Yes No 3b Commercial business interests (e.g., proprietorships, partnerships, joint ventures, board memberships, controlling interest in a company) Yes No INTELLECTUAL PROPERTY Do you have any intellectual property rights that might be enhanced or diminished by the outcome of the meeting or work? 4a Patents, trademarks, or copyrights (including pending applications) Yes No 4b Proprietary know-how in a substance, technology or process Yes No PUBLIC STATEMENTS AND POSITIONS (during the past 3 years) 5a As part of a regulatory, legislative or judicial process, have you provided an expert opinion or testimony, related to the subject of the meeting or work, for a commercial entity or other organization? Yes No 5b Have you held an office or other position, paid or unpaid, where you represented interests or defended a position related to the subject of the meeting or work? Yes No ADDITIONAL INFORMATION 6a If not already disclosed above, have you worked for the competitor of a product that is the subject of the meeting or work, or will your participation in the meeting or work enable you to obtain access to a competitor's confidential proprietary information, or create for you a personal, professional, financial or business competitive advantage? Yes No 6b To your knowledge, would the outcome of the meeting or work benefit or adversely affect interests of others with whom you have substantial common personal, professional, financial or business interests (such as your adult children or siblings, close professional colleagues, administrative unit or department)? Yes No 6c Excluding WHO, has any person or entity paid or contributed towards your travel costs in connection with this WHO meeting or work? Yes No 6d Have you received any payments (other than for travel costs) or honoraria for speaking publicly on the subject of this WHO meeting or work? Yes No 6e Is there any other aspect of your background or present circumstances not addressed above that might be perceived as affecting your objectivity or independence? Yes No
Investment Interests. Obtain the funds via one or more issuances of one or more separate class of Interests ("INVESTMENT INTERESTS"), the terms and conditions of each issuance of which, and the rights, preferences, privileges and obligations associated with the ownership of which, are determined by the Board of Managers and set forth in a written instrument delivered to all Members. Notwithstanding the provisions of Section 6.4, the Board of Managers may amend this Agreement to create and give effect to the rights, preferences, privileges and obligations any class of Investment Interests issued in accordance with this Section 3.2.1(c) without the consent of the Members. Prior to issuing any Investment Interests to outside persons in exchange for funds, such interests shall first be offered to existing Members on a Proportionate basis, and if an existing Member does not purchase his entire Proportionate share of the Investment Interests being offered to him, such share may be purchased by the other Members on a Proportionate basis. This process shall be repeated until all of the Investment Interests have been purchased by the existing Members or until no existing Member has any further interest in purchasing the Investment Interests, but in no event longer than fifteen (15) days after the Board of Managers has sent out a written notice to all Members soliciting the purchase of the Investment Interests and setting forth the material terms and conditions pertinent thereto. If existing Members do not purchase all of the Investment Interests, the unpurchased Investment Interests shall then be offered to outside investors (including any interested Affiliates of one or more of the Members) on the same terms and conditions offered to the Members. Upon issuance of one or more Investment Interests pursuant hereto, the Percentage Interests of all other Members shall be diluted on a Proportionate basis, and the Board of Managers shall revise Exhibit A appropriately and distribute the revised version to all of the Members.
Investment Interests. Seller has good, legal and valid title to the Investment Interests that it is selling hereunder, and such Investment Interests are not subject to any Liens, except for the Required Consents. Part I of Schedule I hereto accurately sets forth the true and correct capital contributions made by each of the Sellers to, and the membership interests of each of the Sellers in, the entities set forth therein. The Investment Interests represent 100% of the interests of the Sellers, their Affiliates, The Enstar Group, Inc. and Castlewood Holdings Limited (other than the Coinvest Interests) in the entities (other than those designated as Sellers on the schedules hereto) set forth on Schedule I, Schedule IV and Schedule V hereto. From the applicable date of acquisition of each of the Investment Interests until the date hereof, none of the Investment Interests have been transferred, assigned, pledged or otherwise disposed of. After the consummation of the transactions contemplated hereby and by the Transaction Documents and the concurrent transfer of the Coinvest Interests, none of the Sellers, their Affiliates, The Enstar Group, Inc. and Castlewood Holdings Limited will have any interest in any of the entities set forth on Schedule I, Schedule IV or Schedule V hereto (other than those designated as Sellers on such schedules).
Investment Interests. Taking into account stocks, bonds, and other financial instruments and investments including partnerships (but excluding broadly diversified mutual funds and any investment or financial interest valued at less than $10,000), if the reports resulting from this activity (e.g., committee service or service as a scientific peer reviewer) were to provide the basis for government regulatory action or inaction with respect to the matters addressed in the reports --
Investment Interests. The parties hereby acknowledge and agree that on February 24, 2010 (the “Investment Date”), the Executive purchased LLC interests in VSH with an aggregate value of $2 million with ownership rights calculated based on the Aggregate Cost Basis (the “Investment Interests”). The terms and conditions of the Investment Interests, including, without limitation, other terms and conditions relating to the purchase of the Investment Interests by the Executive, were documented in an equity purchase agreement between VSH and the Executive, effective as of the Investment Date, and are subject to the terms of the Operating Agreement of VSH, dated as of April 6, 2007 (the “Operating Agreement”).
Investment Interests. This covers current investments in a commercial third party in the biomedical arena and includes stocks, bonds, stock options, or commercial business interests (e.g., proprietorship, partnerships, joint ventures, board memberships, controlling interest in a company). Do you or an immediate family member have current investments in a commercial third party in the biomedical arena? This includes stocks, bonds, stock options, or commercial business interests (e.g., proprietorship, partnerships, joint ventures, board memberships, controlling interest in a company)? If yes, is this investment in conflict (actual, possible, or perceived) with the interests of ERN eUROGEN activities and results you are engaged with? Name of commercial third party Type of Interest Relates to whom? Monetary Value (approx.) COI? (actual / possible / perceived)
